Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Circulation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0735-1097(95)93041-aPMID 7828284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct thrombin inhibitors in cardiovascular medicine.

  1994cited by this paper
• A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries.

  1994cited by this paper
• Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional coronary atherectomy: in vivo evidence of thrombosis, ulceration, and inflammation.

  1994cited by this paper
• Smooth Muscle Cell Abundance and Fibroblast Growth Factors in Coronary Lesions of Patients With Nonfatal Unstable Angina A Clue to the Mechanism of Transformation From the Stable to the Unstable Clinical State

  1993cited by this paper
• Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

  1993cited by this paper
• The role of tissue factor in the production of thrombin.

  1993cited by this paper
• The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions.

  1993cited by this paper
• Angioscopic coronary macromorphology in patients with acute coronary disorders.

  1991cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

  1989cited by this paper
• Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications

  1989cited by this paper
• Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

  1986cited by this paper
• Angiographic morphology and the pathogenesis of unstable angina pectoris.

  1985cited by this paper
• Tissue factor revisited.

  1982cited by this paper

• Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting

  2024cites this paper
• Developing a Biomimetic 3D Neointimal Layer as a Prothrombotic Substrate for a Humanized In Vitro Model of Atherothrombosis

  2024cites this paper
• PCSK9 aggravated carotid artery stenosis in ApoE-/- mice by promoting the expression of tissue factors in endothelial cells via the TLR4/NF-κB pathway.

  2024cites this paper
• C-Reactive Protein Signaling Pathways in Tumor Progression

  2023cites this paper
• Platelet-monocyte aggregates: molecular mediators of thromboinflammation

  2023cites this paper
• Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.

  2022cites this paper
• Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis

  2022cites this paper
• LPA1-mediated PKD2 activation promotes LPA-induced tissue factor expression via the p38α and JNK2 MAPK pathways in smooth muscle cells

  2021cites this paper
• Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes

  2021cites this paper
• Tissue factor in atherosclerosis and atherothrombosis.

  2020cites this paper
• COVID-19-associated vasculitis and vasculopathy

  2020cites this paper
• Evaluation of plasma levels of tissue factor and tissue factor pathway inhibitor in patients with psoriasis

  2019cites this paper
• A study of clinicopathological characteristics, symptoms and patients experiences related to outcomes in people with cancer and I-PE

  2019cites this paper
• KLF11 (Krüppel-Like Factor 11) Inhibits Arterial Thrombosis via Suppression of Tissue Factor in the Vascular Wall

  2019cites this paper
• Overexpression of tissue factor induced atherothrombosis in apolipoprotein E-/- mice via both enhanced plaque thrombogenicity and plaque instability.

  2019cites this paper
• Nobiletin inhibits oxidized‐LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF‐&kgr;B

  2017cites this paper
• Activated Monocytes Enhance Platelet-Driven Contraction of Blood Clots via Tissue Factor Expression

  2017cites this paper
• FVIIa-antithrombin levels in early and late preeclampsia.

  2017cites this paper
• Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation

  2016cites this paper
• Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt–NF-κB axis

  2016cites this paper
• Tissue Factor and Atherothrombosis.

  2015cites this paper
• Leukocyte Activation in Obese Patients

  2015cites this paper
• 1502 Stroke June 2015 contribute to a procoagulant state in patients with acute cardiac and brain

  2015cites this paper
• Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor

  2015cites this paper
• Circulating Tissue Factor Levels and Risk of Stroke: Findings From the EPICOR Study

  2015cites this paper
• Oxidation-specific epitopes are major targets of innate immunity in atherothrombosis

  2015cites this paper
• Endothelial connexin 32 regulates tissue factor expression induced by inflammatory stimulation and direct cell-cell interaction with activated cells.

  2014cites this paper
• Differences in intravascular ultrasound and histological findings in culprit coronary plaques between ST-segment elevation myocardial infarction and stable angina

  2014cites this paper
• The antithrombotic effects of statins.

  2014cites this paper
• The adipokine apelin-13 induces expression of prothrombotic tissue factor

  2014cites this paper
• MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor.

  2014cites this paper
• MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells.

  2014cites this paper
• High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation

  2014cites this paper
• Protective and pathological roles of tissue factor in the heart

  2014cites this paper
• Chronic HIV disease and activation of the coagulation system.

  2013cites this paper
• Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction

  2013cites this paper
• Depletion of systemic concentrations of coagulation factors in blood from patients with atherosclerotic vascular disease

  2013cites this paper
• The biology behind the atherothrombotic effects of cigarette smoke

  2013cites this paper
• Comparison of intravascular ultrasound and histological findings in culprit coronary plaques between ST-segment elevation and non-ST-segment elevation myocardial infarction.

  2013cites this paper
• Protein anticoagulants targeting factor VIIa–tissue factor complex: a comprehensive review

  2013cites this paper
• [(18)F]-fluorodeoxyglucose. A new imaging modality for atherosclerotic plaque thrombogenicity.

  2013cites this paper
• Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy

  2012cites this paper
• Resistin: functional roles and therapeutic considerations for cardiovascular disease

  2012cites this paper
• An investigation into the role of platelet-monocyte interaction and inflammation in coronary artery disease

  2012cites this paper
• The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle.

  2012cites this paper
• Sources of tissue factor that contribute to thrombosis after rupture of an atherosclerotic plaque.

  2012cites this paper
• Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.

  2012cites this paper
• Role of Tissue Factor in Atherothrombosis

  2012cites this paper
• Biobanking in Atherosclerotic Disease, Opportunities and Pitfalls

  2011cites this paper
• Comparison of ruptured coronary plaques in patients with unstable and stable clinical presentation

  2011cites this paper
• The hemostatic system as a modulator of atherosclerosis.

  2011cites this paper
• Management of the no-reflow phenomenon.

  2011cites this paper
• Effects of Fondaparinux and a Direct Factor Xa Inhibitor TAK-442 on Platelet-associated Prothrombinase in the Balloon-injured Artery of Rats

  2011cites this paper
• Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis

  2011cites this paper
• Dose-dependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein.

  2011cites this paper
• Protective roles of SIRT1 in atherosclerosis

  2011cites this paper
• Plasma tissue factor, tissue factor pathway inhibitor and restenosis following femoropopliteal percutaneous transluminal angioplasty in claudicants

  2011cites this paper
• Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.

  2011cites this paper
• Metformin, an Antidiabetic Agent, Suppresses the Production of Tumor Necrosis Factor and Tissue Factor by Inhibiting Early Growth Response Factor-1 Expression in Human Monocytes in Vitro

  2010cites this paper
• Tissue factor and cardiovascular disease: quo vadis?

  2010cites this paper
• Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia.

  2010cites this paper
• Pharmacological modulation of vascular inflammation in atherothrombosis

  2010cites this paper
• [The role of tissue factor and tissue factor pathway inhibitor in blood coagulation and in thrombotic complications].

  2010cites this paper
• Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.

  2010cites this paper
• Tissue Factor Is Induced by Resistin in Human Coronary Artery Endothelial Cells by the NF-ĸB-Dependent Pathway

  2010cites this paper
• Review article: Coagulation and fibrinolysis in diabetes

  2010cites this paper
• Tissue factor in cardiovascular disease pathophysiology and pharmacological intervention.

  2010cites this paper
• Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?

  2010cites this paper
• High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-κB and Egr-1

  2009cites this paper
• Tissue factor: beyond coagulation in the cardiovascular system.

  2009cites this paper
• Tissue factor gene polymorphisms and haplotypes and the risk of ischemic vascular events: four studies and a meta‐analysis

  2009cites this paper
• Plasma tissue factor in coronary artery disease: further step to the understanding of the basic mechanisms of coronary artery thrombosis.

  2008cites this paper
• Past, current and future concepts in atherosclerotic biobanking.

  2008cites this paper
• Does tissue factor expression by vascular smooth muscle cells provide a link between C-reactive protein and cardiovascular disease?

  2008cites this paper
• Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells

  2008cites this paper
• Wirkungsweise alter und neuer Antikoagulanzien

  2008cites this paper
• Ambient air particulate matter exposure and tissue factor expression in atherosclerosis.

  2008cites this paper
• Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.

  2008cites this paper
• Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study

  2007cites this paper
• The role of tissue factor in thrombosis and hemostasis.

  2007cites this paper
• Alprostadil and pentoxifylline influence on the ability of monocytes to release extrinsic pathway factors in patients with peripheral arterial occlusive disease

  2007cites this paper
• Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy

  2007cites this paper
• A novel anti-tissue factor monoclonal antibody with anticoagulant potency derived from synthesized multiple antigenic peptide through blocking FX combination with TF.

  2007cites this paper
• Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro.

  2007cites this paper
• CHAPTER 8 – Molecular Basis of Lipoprotein Disorders, Atherogenesis, and Thrombosis

  2007cites this paper
• Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications

  2006cites this paper
• Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism

  2006cites this paper
• Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes.

  2006cites this paper
• Carotenoids enhance phosphorylation of Akt and suppress tissue factor activity in human endothelial cells.

  2006cites this paper
• Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents

  2006cites this paper
• The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.

  2006cites this paper
• Tissue factor in hemostasis and thrombosis.

  2006cites this paper
• Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation.

  2006cites this paper
• Coronary plaque composition of culprit/target lesions according to the clinical presentation: a virtual histology intravascular ultrasound analysis.

  2006cites this paper
• On the genetic variation of interleukin-6 in health and coronary heart disease

  2005cites this paper
• The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trial.

  2005cites this paper
• C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation.

  2005cites this paper
• Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial.

  2005cites this paper
• Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression

  2005cites this paper
• Understanding the dynamics of thrombin in cardiovascular disease: pathobiology and biochemistry for the clinician.

  2005cites this paper